Safety and activity of the TGFβ receptor i kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
- Melisi, D.
- Oh, D.-Y.
- Hollebecque, A.
- Calvo, E.
- Varghese, A.
- Borazanci, E.
- Macarulla, T.
- Merz, V.
- Zecchetto, C.
- Zhao, Y.
- Gueorguieva, I.
- Man, M.
- Gandhi, L.
- Estrem, S.T.
- Benhadji, K.A.
- Lanasa, M.C.
- Avsar, E.
- Guba, S.C.
- Garcia-Carbonero, R.
Zeitschrift:
Journal for ImmunoTherapy of Cancer
ISSN: 2051-1426
Datum der Publikation: 2021
Ausgabe: 9
Nummer: 3
Art: Artikel